Trials / Completed
CompletedNCT03851289
Combination of Platelet-Rich Fibrin and Calcium Sulfate in Socket Augmentation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Malaya · Academic / Other
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study evaluated the effectiveness of socket grafting material, combination of plate-rich fibrin and calcium sulfate. 5 subjects were grafted with this material, 5 subjects were grafted with combination of plate-rich fibrin and xenograft.
Detailed description
Calcium sulfate (CS), an alloplastic material, is widely accepted as a socket grafting material and undergoes rapid and complete resorption. Studies have shown that CS creates an osteoconductive lattice that stimulates bone ingrowth into a defect. PRF poses multiple growth factors, anti-inflammatory cytokines and adhesion molecules. It is biologically active up to one week. The combination of these 2 materials will serve as good grafting material for tooth socket, in order to preserve vertical and horizontal dimensions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | platelet-rich fibrin and calcium sulfate | |
| COMBINATION_PRODUCT | platelet-rich fibrin and xenograft |
Timeline
- Start date
- 2016-04-22
- Primary completion
- 2017-07-14
- Completion
- 2018-02-06
- First posted
- 2019-02-22
- Last updated
- 2020-03-25
Source: ClinicalTrials.gov record NCT03851289. Inclusion in this directory is not an endorsement.